signal

A unique collection of 1120 compounds targeting NF-κB signaling for high throughput screening and high content screening;

A unique collection of 263 kinase inhibitors/regulators for specific targeting of kinases, ready for high-throughput screening and high-content screening.

A unique collection of 1796 annotated bioactive compounds with clear targets, suitable for phenotypic screening;

A unique collection of 924 compounds targeting endocrine system for high throughput screening (HTS) and high content screening (HCS) for new drugs;

A unique collection of 210 TGF-beta/Smad signaling targeted compounds for high throughput and high content screening;

A unique collection of 530 JAK/STAT signaling targeted compounds for high throughput and high content screening;

A unique collection of 1150 cytoskeleton-related compounds, can be used for HTS and HCS;

A unique collection of 3500 compounds targeting CNS signaling for high throughput screening (HTS) and high content screening (HCS) for new drugs;

A unique collection of 2080 HIF-1 related small chemicals can be used for drug discovery in ischemic disease and cancer and related mechanism studies;

A unique collection of 3660 drugs with anti-cancer activity or potential anti-cancer activity for high throughput screening (HTS) and high content screening (HCS);

A collection of 19170 small molecule compounds with validated activity for high throughput screening (HTS), high content screening (HCS), cell induction, and target identification;

120 well-chosen unique AMPK-targeted small molecules;

A unique collection of 861 compounds targeting MAPK signaling for drug discovery in MAPK related diseases;

A unique collection of 815 compounds targeting cytokine signaling for high throughput screening and high content screening for drug discovery;

A unique collection of 530 Wnt/Hedgehog/Notch signaling targeted compounds for high throughput and high content screening;

A unique collection of 300 calcium channel blockers and agonists for high throughput and high content screening;

A unique collection of 89 chemokines or chemokine receptors targeted compounds for high throughput and high content screening;

A unique collection of 2850 GPCR-active agents for high throughput screening and high content screening for GPCR drug discovery, and new GPCR target identification and research;

A unique collection of 3245 kinase inhibitors/regulators for high throughput screening and high content screening for drug discovery in kinase related diseases;

Membrane proteins are a class of proteins widely found in biological cell membranes, playing essential roles in the structure and function of cells. Based on their location and function, membrane proteins can be classified into three main categories: peripheral membrane proteins, integral membrane proteins, and lipid-anchored proteins. Membrane proteins encompass a variety of functional proteins, including glycoproteins, carrier proteins, and enzymes. They are often linked to carbohydrate molecules, which can transmit signals into the cell by undergoing structural changes, participating in signal transduction processes. Membrane proteins perform a range of critical functions, including substance transport, signal transduction, cell recognition, and energy conversion. In drug development, membrane proteins, especially G protein-coupled receptors (GPCRs), ion channels, and transporters, are of particular interest. Many diseases are related to the malfunction of specific membrane proteins. Therefore, drugs designed to target these proteins can regulate their activity, aiming to treat diseases. TargetMol has collected 6422 compounds that target membrane proteins, which can be used for membrane protein-related scientific research and drug screening, suitable for high-throughput and high-content screening.

A unique collection of 1350 tyrosine kinase inhibitors for high throughput screening and high content screening for drug discovery in tyrosine kinase related diseases;

A unique collection of 2780 pain-related compounds for high throughput screening (HTS) and high content screening (HCS);

A unique collection of 149 neuroregeneration related compounds for high throughput and high content screening;

A collection of 470 bitter compounds, suitable for high-throughput and high-content screening;